LEQVIO (inclisiran) Patient Assistance Program
Don’t let the high cost of brand specialty PCSK9-targeting siRNA therapy disrupt your treatment. We help eligible patients access Leqvio (inclisiran) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Leqvio (inclisiran) is FDA-approved as an adjunct to diet and maximally tolerated statin therapy for adults with primary hyperlipidemia (including heterozygous familial hypercholesterolemia) and adults with established cardiovascular disease who need additional LDL-C lowering. It is a first-in-class small interfering RNA (siRNA) targeting PCSK9 — given as twice-yearly subcutaneous injection.
- Without assistance, Leqvio costs commonly run approximately $3,200–$3,800 per dose (given every 6 months after loading) — annual cost ~$6,400–$7,600.
- Through AffordMyPrescriptions, qualifying patients can access Leqvio for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no biosimilar of Leqvio in the U.S. as of 2026. PCSK9 monoclonal antibodies (Repatha/evolocumab, Praluent/alirocumab) are alternative PCSK9-targeting therapies given by self-injection every 2–4 weeks. Generic high-intensity statins (atorvastatin, rosuvastatin) and generic ezetimibe remain the foundation of lipid-lowering therapy and are dramatically cheaper.
What Is Leqvio Prescription Assistance Program?
The Leqvio Prescription Assistance Program is a manufacturer-sponsored initiative that provides Leqvio at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for hyperlipidemia patients requiring additional LDL-C lowering who are uninsured or underinsured, as well as Medicare Part B/D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, cardiology/lipidology coordination, prior-authorization documentation (often requiring documented inadequate response to high-intensity statins ± ezetimibe), specialty pharmacy or buy-and-bill logistics, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing injection-coordination and re-certification.
Pharmacy Price Comparison
- Without assistance, Leqvio costs roughly $3,200–$3,800 per dose. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$3,700/dose | Save substantially |
| CVS Pharmacy | ~$3,800/dose | Save substantially |
| Walmart | ~$3,400/dose | Save substantially |
| Costco | ~$3,300/dose | Save substantially |
Specialty Pharmacy | ~$3,500/dose | Save substantially |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Leqvio Prescription Program?
The Patient Assistance Program is free to apply for and provides Leqvio at no medication cost if approved. Our $69.95/month service covers full advocacy. Generic high-intensity statins + generic ezetimibe achieve substantial LDL-C lowering at very low cost; Leqvio is added when additional lowering is needed beyond what these agents can achieve.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Leqvio:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $3,200–$3,800/dose per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Leqvio assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Leqvio Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Leqvio :
Leqvio (inclisiran) is a first-in-class small interfering RNA (siRNA) that targets PCSK9 messenger RNA in the liver. By degrading PCSK9 mRNA, Leqvio reduces PCSK9 protein production — which in turn raises LDL receptor density on hepatocytes and lowers circulating LDL cholesterol. Given as a twice-yearly subcutaneous injection in a healthcare provider setting.
How Leqvio Works:
PCSK9 is a liver protein that naturally breaks down LDL receptors, leaving fewer receptors available to clear bad cholesterol from the blood. Leqvio works as a small interfering RNA (siRNA) that directly targets and stops the liver from producing the PCSK9 protein. With less PCSK9 available, more LDL receptors remain active on liver cells to clear cholesterol, resulting in roughly a 50% reduction in LDL-C. This advanced siRNA mechanism provides a highly durable effect, allowing long-term cholesterol lowering with just two maintenance doses per year.
Form and use:
Leqvio is administered as a 284 mg subcutaneous injection that must be given by a healthcare provider in an office or infusion center. The treatment schedule begins with an initial injection, followed by a second loading dose at month three, and then a regular maintenance dose once every six months thereafter. Patients do not require any extra lipid monitoring beyond their typical, routine cholesterol blood panels. The medication is distributed to providers through specialty pharmacy or buy-and-bill channels.
Generic availability:
As of 2026, there is no generic or biosimilar version of Leqvio available in the United States. Other brand-name PCSK9 therapies include Repatha and Praluent, which are monoclonal antibodies that patients must self-inject every two to four weeks. Affordable mainstay alternatives include generic high-intensity statins like atorvastatin or rosuvastatin combined with generic ezetimibe, which can also lower LDL-C by 40% to 60%. Consequently, advanced therapies like Leqvio are generally reserved for statin-intolerant patients or those who cannot lower their cholesterol adequately on maximum-dose statins.
Warnings:
Leqvio is well-tolerated and features a generally favorable safety profile with no clear liver, muscle, or neurocognitive risks identified to date. The most common side effects reported by patients include mild injection-site reactions, joint pain, urinary tract infections, diarrhea, bronchitis, extremity pain, and shortness of breath. Rare hypersensitivity reactions can still occur, and because safety data regarding pregnancy is currently limited, its use should generally be avoided during pregnancy.
FAQ (Frequently Asked Questions)
How Much Does Leqvio Cost Without Insurance?
Leqvio costs approximately $3,200–$3,800 per dose, with dosing every 6 months after loading — annual cost ~$6,400–$7,600. Through AffordMyPrescriptions, qualifying patients receive Leqvio at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Is Leqvio Different From Repatha Or Praluent?
Leqvio costs approximately $3,200–$3,800 per dose, with dosing every 6 months after loading — annual cost ~$6,400–$7,600. Through AffordMyPrescriptions, qualifying patients receive Leqvio at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Is Leqvio Different From Repatha Or Praluent?
All three lower LDL-C by targeting PCSK9. Repatha (evolocumab) and Praluent (alirocumab) are monoclonal antibodies that bind PCSK9 protein in blood — self-injected SC every 2 or 4 weeks. Leqvio (inclisiran) is a siRNA that prevents PCSK9 production in the liver — given by healthcare provider injection every 6 months. The dosing frequency difference is the main practical distinction — Leqvio’s twice-yearly schedule eliminates self-injection burden but requires office visits.
Should I Try Generic Statins And Ezetimibe First?
Yes — and almost certainly you should be on them. Generic high-intensity statins (atorvastatin 40–80 mg or rosuvastatin 20–40 mg) plus generic ezetimibe achieve 40–60% LDL-C reduction at very low cost ($14–$45/month combined). These should be maximized before adding PCSK9-targeting therapy. Insurance plans almost universally require documented inadequate response to these cheaper options before approving Leqvio, Repatha, or Praluent.
How Quickly Will My LDL-C Drop?
Significant LDL-C reduction is typically seen by 14 days after the first dose, with maximum reduction by 60 days. After loading doses (day 0 and month 3), maintenance every 6 months keeps LDL-C suppressed. LDL-C reductions average ~50% beyond background statin therapy.
Can I Stop My Statin When I Start Leqvio?
Generally no. Leqvio is approved as an ADJUNCT to maximally tolerated statin therapy. The cardiovascular benefit of statins extends beyond LDL-C lowering (pleiotropic effects). Both statin AND Leqvio are typically continued together. Some patients with true statin intolerance may use Leqvio with ezetimibe or alone, but this is less common.
Can I Get Leqvio Through The PAP If I Have Medicare?
Yes. Leqvio is typically billed through Medicare Part B (provider-administered injection); the PAP can help with copays or for patients without insurance. The manufacturer’s commercial copay savings program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If denied, we explore alternatives — optimizing generic statin + generic ezetimibe (very low cost) for the LDL-lowering target, switching to a PCSK9 monoclonal antibody (Repatha, Praluent) with its own PAP, the manufacturer’s copay program for commercially insured patients, or independent foundations such as the American Heart Association, FH Foundation, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Leqvio, our team may be able to help you access assistance programs designed to make brand specialty PCSK9-targeting siRNA therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.